Results of a Phase II Study of LHRH Therapy in High-Risk Prostate Cancer
March 15th 2018Bridget F. Koontz, MD, associate professor of radiation oncology, Duke Cancer Institute, discusses a single-arm, phase II trial of 6 months of concurrent androgen deprivation therapy/abiraterone acetate (Zytiga) plus prednisone and definitive radiotherapy for men with intermediate- to high-risk localized prostate cancer.
Watch
Choosing Treatment Regimens in Patients with Triple-Negative Breast Cancer
March 14th 2018Hyman B. Muss, MD, professor of medicine, UNC Lineberger Comprehensive Cancer Center, University of North Carolina-Chapel Hill School of Medicine, discusses how he chooses which treatment to use for patients diagnosed with triple-negative breast cancer (TNBC).
Watch
Results for the Combination of Nivolumab and Ibrutinib in Non-Hodgkin Lymphoma and CLL
March 14th 2018Anas Younes, MD, chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, discusses results from a trial studying the combination of nivolumab and ibrutinib for the treatment of patients with relapsed non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Watch
Methods Used for Ovary Suppression in Women with Breast Cancer
March 13th 2018Harold J. Burstein, MD, PhD, a medical oncologist at the Dana-Farber Cancer Institute, explains how ovary suppression is done in patients with breast cancer. This is a particularly important treatment for younger women who still wish to have children one day.
Watch
Using Immunotherapy for the Treatment of mCRC
March 12th 2018Thierry Andre, MD, a professor of medical oncology at the University Pierre et Marie Curie, and Head of the Medical Oncology Department in St. Antoine Hospital, Assistance Publique Hôpitaux de Paris, discusses factors that a community oncologist should consider when choosing the right treatment for patients with metastatic colorectal cancer.
Watch
The Role of Biomarkers in Patients with Breast Cancer
March 8th 2018Susan M. Domchek, MD, director of the Basser Center for BRCA at Penn Medicine, discusses the role biomarkers have in the treatment of patients with breast cancer. Identifying biomarkers in patients early on, such as knowledge of estrogen receptor status, can lead to better treatment plans, Domchek says.
Watch
The Biggest Issue with Treatment of Breast Cancer in Men
March 8th 2018Fatima Cardoso, MD, medical oncologist at the Champalimaud Clinical Centre in Portugal, explains the biggest issue in treatment of male breast cancer is due to lack of education. Male patients are most commonly diagnosed in the advanced stages because of this and are commonly given the wrong treatments, says Cardoso.
Watch
Identifying Treatment Regimens for Patients with Multiple Myeloma
March 7th 2018Ajai Chari, MD, associate professor of medicine at the Mount Sinai School of Medicine, advises on the best way to choose treatment regimens for patients with multiple myeloma. Since 9 different drugs have been approved after many phase III trials, a community physician may be overwhelmed by this surplus of options, Chari says.
Watch
Using PET or CT for Staging Patients with Follicular Lymphoma
March 7th 2018Anas Younes, MD, chief of the Lymphoma Service at Memorial Sloan Kettering Cancer Center, discusses current research for staging patients with follicular lymphoma. In order to design new clinical trials, researchers must have reliable predictors of overall survival and progression-free survival in patients.
Watch
A Look at Mutations in Patients with High-Risk Multiple Myeloma
March 7th 2018Shaji Kumar, MD, professor of medicine in the Division of Hematology at the Mayo Clinic, discusses the effects genetic abnormalities have on patients with high-risk multiple myeloma. Recent advancements have helped to identify these abnormalities in patients.
Watch